SYMPHONIX DEVICES DL-,001 - 500 Beiträge pro Seite

[Miriana]

Wollte noch mal zum Jahresabschluß ein paar Taler verzocken..*frechgrins*

Und plötzlich bin ich über diese Aktie gestolpert....****


SYMPHONIX DEVICES DL-,001 WKN: 912376

Ich werde mal ein Paar einkaufen ...*lol*

Gruß
Miri

[mr.Seefeld]

Bitte mit News oder verschone uns! Bist wohl gestern billig rein! Ist immer das selbe Spiel mit der Aktie.

[Miriana]

Was heißt güntig reingekommen ???
Das Schätzchen ist günstig....*lol*

SYMPHONIX DEVICES DL-,001 an der Börse Frankfurt
Datum Eröffnung Hoch Tief Letzter Volumen
05.12.2002 0,11 0,13 0,09 0,09 38260
04.12.2002 0,14 0,14 0,11 0,12 11270
03.12.2002 0,16 0,18 0,15 0,15 32730
02.12.2002 0,11 0,19 0,11 0,15 116285
29.11.2002 0,07 0,10 0,07 0,10 11035
28.11.2002 0,07 0,07 0,07 0,07 0
27.11.2002 0,07 0,07 0,07 0,07 200
26.11.2002 0,07 0,08 0,07 0,08 13135
25.11.2002 0,13 0,13 0,07 0,08 90760
22.11.2002 0,07 0,07 0,06 0,06 11000
21.11.2002 0,08 0,08 0,07 0,07 5000
20.11.2002 0,09 0,11 0,08 0,08 67050
19.11.2002 0,06 0,09 0,06 0,09 6500
18.11.2002 0,07 0,07 0,06 0,06 19470
15.11.2002 0,09 0,10 0,09 0,09 7037
14.11.2002 0,24 0,25 0,09 0,09 6130
13.11.2002 0,26 0,26 0,26 0,26 0
12.11.2002 0,25 0,25 0,25 0,25 0
11.11.2002 0,25 0,26 0,25 0,26 2000
08.11.2002 0,30 0,30 0,30 0,30 0
07.11.2002 0,35 0,35 0,32 0,32 600
06.11.2002 0,35 0,35 0,35 0,35 0
05.11.2002 0,38 0,38 0,38 0,38 0
04.11.2002 0,35 0,35 0,35 0,35 0

[Miriana]

Mal gucken was die Woche bringt.....*lol*

$$$$

[brazzil]

@ all

SAN JOSE, Calif., March 21 /PRNewswire-FirstCall/ -- Symphonix(R) Devices Inc. -- developers of the world``s first FDA-approved middle-ear implant for moderate to severe sensorineural hearing loss -- announced today that it has entered into a definitive agreement with MED-EL, GmbH, a leading company in the field of cochlear implants with headquarters in Innsbruck, Austria, under which MED-EL has agreed to purchase certain assets and assume certain liabilities of Symphonix.
Under the terms of the definitive asset purchase agreement, MED-EL will pay $2.5 million to Symphonix in exchange for ownership of certain Symphonix assets including inventory, property & equipment and intellectual property and the assumption of all patient-related liabilities, including the warranty of all Vibrant Soundbridges currently in use. Geoff Ball, inventor of the Vibrant(R) Soundbridge(R), co-founder of Symphonix, and current Symphonix Chief Technology Officer, will become MED-EL``s new middle-ear implant Chief Technology Officer based out of the Innsbruck, Austria worldwide headquarters. Deborah Arthur, Head of Clinical & Regulatory Affairs for Symphonix will take on the same role for MED-EL US at their Durham, North Carolina office.
The transaction is subject to the approval of Symphonix`` shareholders, as well as other customary conditions. Symphonix expects the transaction to close in the second quarter of 2003.
The Vibrant Soundbridge product represents an innovative approach to hearing improvement -- the first implantable middle ear hearing device. Unlike conventional acoustic hearing aids, which increase the volume of sound that goes to the eardrum, the Vibrant Soundbridge bypasses the ear canal and eardrum by directly vibrating the small bones in the middle ear. Because of its design, no portion of the device is placed in the ear canal itself. The Vibrant Soundbridge has been approved by the FDA as a safe and effective treatment option for adults with moderate to severe sensorineural hearing loss who desire an alternative to acoustic hearing aids.
About Symphonix Devices, Inc.
Symphonix Devices Inc., a hearing technology company in the process of dissolution, had developed products to improve communication ability and quality of life for the millions of hearing-impaired people who were limited by current hearing solutions. Symphonix`` Vibrant Soundbridge is a surgical implant designed to work with the natural structures of the middle-ear to enhance hearing and communication ability for people with hearing impairment. The device can be implanted during a short, outpatient medical procedure. More information about Symphonix Devices, Inc. and their dissolution can be found at http://www.symphonix.com/.
About MED-EL
Over 25 years ago researchers who later founded MED-EL developed one of the world``s first cochlear implants. Today, MED-EL is growing faster than any other cochlear implant company and is the global leader in innovative technology in the field. MED-EL products are the result of collaborative efforts by MED-EL engineers, surgeons, audiologists, therapists, and of course, implant users.
MED-EL has their worldwide headquarters in Innsbruck, Austria, a North American headquarters in Durham, North Carolina and 13 other subsidiaries worldwide. MED-EL has implanted their devices in over 400 clinics, in 70 countries worldwide.
Statements made in the press release regarding the future performance of our business, including the sale of our inventory, property and equipment, intellectual property and patient related liabilities to MED-EL are "forward-looking statements" and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made. Such risks and uncertainties include, but are not limited to, the Company``s shareholders not approving the complete liquidation and dissolution of the company and the sale of the majority of the company``s assets to MED-EL. Further information on potential factors that could affect the Company``s financial results is included in the Company``s Form 10-Q for the quarter ending September 30 2002, and Form 10-K for the 2001 fiscal year filed with the Securities and Exchange Commission.
NOTE: Symphonix, Vibrant and Soundbridge are registered trademarks of Symphonix Devices, Inc.
CONTACT: Eric Gertsman of Neale-May & Partners, [phone], ext. 502, or [e-mail], for Symphonix Devices Inc.; or investors, Terry Griffin, CFO of Symphonix Devices Inc., [phone].
Symphonix Devices Inc.
© PR Newswire

[brazzil]

@ all

SAN JOSE, Calif., March 25 /PRNewswire-FirstCall/ -- Symphonix(R) Devices Inc. -- developers of the world``s first FDA-approved middle-ear implant for moderate to severe sensorineural hearing loss -- announced today that its common stock will be delisted from the Nasdaq Market before the opening bell on March 28, 2003 and will commence trading that same day on the Over-the-Counter Bulletin Board (OTCBB).

The decision by the Nasdaq Listing Qualifications Panel to delist Symphonix was based on the company``s failure to meet Nasdaq``s minimum $1 bid price per share requirement.
The OTCBB is a regulated quotation service that displays real-time quotes, last-sale prices and volume information in over-the-counter equity securities. OTCBB securities are traded by a community of market makers that enter quotes and trade reports. The company``s common stock will trade under the ticker symbol SMPX and can be viewed at http://www.otcbb.com/.

About Symphonix Devices, Inc.
Symphonix Devices Inc., a hearing technology company in the process of dissolution, has developed products to improve communication ability and quality of life for the millions of hearing-impaired people who were limited by current hearing solutions. Symphonix`` Vibrant Soundbridge is a surgical implant designed to work with the natural structures of the middle-ear to enhance hearing and communication ability for people with hearing impairment. The device can be implanted during a short, outpatient medical procedure. More information about Symphonix Devices, Inc. its dissolution and the selling of the majority of its assets to MED-EL can be found at http://www.symphonix.com/.

Statements made in the press release regarding dissolution, the delisting of our securities by Nasdaq and the commencement of trading of our securities on the OTCBB are "forward looking statements" and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made. Such risks and uncertainties include, but are not limited to receiving stockholder approval of the dissolution. Further information on potential factors that could affect the company`` is included in the company``s Form 10-Q for the quarter ending September 30 2002, and Form 10-K for the 2001 fiscal year filed with the Securities and Exchange Commission.
Symphonix, Vibrant and Soundbridge are registered trademarks of Symphonix Devices, Inc.
Media Relations: Eric Gertsman Neale-May & Partners [phone] x502 [e-mail] Investor Relations: Terry Griffin, CFO [phone]
Symphonix Devices Inc.